Literature DB >> 2290876

Lower respiratory tract infections.

A Billas1.   

Abstract

Although lower respiratory tract infections are frequently diagnosed in a primary care setting, they are still associated with a significant morbidity and mortality, which warrants a careful approach to treatment. Knowledge of the most common cause based on the age of the patient, location where the infection was acquired, and clinical presentation helps to direct empiric treatment. A few basic laboratory studies, especially a sputum Gram stain, can allow for more specific treatment. Identification of patients at increased risk for virulent organisms should make the primary care physician consider inpatient treatment along with an aggressive diagnostic workup and broad-spectrum antimicrobial treatment. Prevention should always be considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2290876

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  6 in total

1.  Roxithromycin versus cefaclor in lower respiratory tract infection: a general practice pharmacoeconomic study.

Authors:  W G Scott; M W Tilyard; S M Dovey; B Cooper; H M Scott
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

2.  Public beliefs and use of antibiotics for acute respiratory illness.

Authors:  A A Wilson; L A Crane; P H Barrett; R Gonzales
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

3.  Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.

Authors:  A P Sachs; G H Koëter; K H Groenier; D van der Waaij; J Schiphuis; B Meyboom-de Jong
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

4.  Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice.

Authors:  N C Karalus; J E Garrett; S D Lang; R A Leng; G N Kostalas; R T Cursons; B C Cooper; C J Ryan
Journal:  Infection       Date:  1995       Impact factor: 3.553

5.  A comparative study of the etiology of adult upper and lower respiratory tract infections in the community.

Authors:  David Lieberman; Devora Lieberman; Igor Korsonsky; Miriam Ben-Yaakov; Zilia Lazarovich; Maureen G Friedman; Bella Dvoskin; Maija Leinonen; Bella Ohana; Ida Boldur
Journal:  Diagn Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.803

6.  Antibiotics in acute bronchitis: a meta-analysis.

Authors:  S Bent; S Saint; E Vittinghoff; D Grady
Journal:  Am J Med       Date:  1999-07       Impact factor: 4.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.